These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 35158994)
1. Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and Utilization. Majuelos-Melguizo J; Rodríguez-Vargas JM; Martínez-López N; Delgado-Bellido D; García-Díaz Á; Yuste VJ; García-Macía M; López LM; Singh R; Oliver FJ Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158994 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. Tentori L; Ricci-Vitiani L; Muzi A; Ciccarone F; Pelacchi F; Calabrese R; Runci D; Pallini R; Caiafa P; Graziani G BMC Cancer; 2014 Mar; 14():151. PubMed ID: 24593254 [TBL] [Abstract][Full Text] [Related]
3. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells. Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061 [TBL] [Abstract][Full Text] [Related]
4. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair. Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. Gariani K; Ryu D; Menzies KJ; Yi HS; Stein S; Zhang H; Perino A; Lemos V; Katsyuba E; Jha P; Vijgen S; Rubbia-Brandt L; Kim YK; Kim JT; Kim KS; Shong M; Schoonjans K; Auwerx J J Hepatol; 2017 Jan; 66(1):132-141. PubMed ID: 27663419 [TBL] [Abstract][Full Text] [Related]
6. Assessing fatty acid-induced lipotoxicity and its therapeutic potential in glioblastoma using stimulated Raman microscopy. Yuan Y; Shah N; Almohaisin MI; Saha S; Lu F Sci Rep; 2021 Apr; 11(1):7422. PubMed ID: 33795756 [TBL] [Abstract][Full Text] [Related]
7. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma. Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921 [TBL] [Abstract][Full Text] [Related]
8. PARP-1-Targeted Radiotherapy in Mouse Models of Glioblastoma. Jannetti SA; Carlucci G; Carney B; Kossatz S; Shenker L; Carter LM; Salinas B; Brand C; Sadique A; Donabedian PL; Cunanan KM; Gönen M; Ponomarev V; Zeglis BM; Souweidane MM; Lewis JS; Weber WA; Humm JL; Reiner T J Nucl Med; 2018 Aug; 59(8):1225-1233. PubMed ID: 29572254 [TBL] [Abstract][Full Text] [Related]
9. Lipid Droplets Maintain Energy Homeostasis and Glioblastoma Growth via Autophagic Release of Stored Fatty Acids. Wu X; Geng F; Cheng X; Guo Q; Zhong Y; Cloughesy TF; Yong WH; Chakravarti A; Guo D iScience; 2020 Oct; 23(10):101569. PubMed ID: 33083736 [TBL] [Abstract][Full Text] [Related]
11. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma. Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. Venere M; Hamerlik P; Wu Q; Rasmussen RD; Song LA; Vasanji A; Tenley N; Flavahan WA; Hjelmeland AB; Bartek J; Rich JN Cell Death Differ; 2014 Feb; 21(2):258-69. PubMed ID: 24121277 [TBL] [Abstract][Full Text] [Related]
13. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221 [TBL] [Abstract][Full Text] [Related]
14. Oleic acid-induced defective autolysosome shows impaired lipid degradation. Lee DH; Ahn J; Jang YJ; Ha TY; Jung CH Biochem Biophys Res Commun; 2019 Jun; 513(3):553-559. PubMed ID: 30981498 [TBL] [Abstract][Full Text] [Related]
15. Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression. Wang YT; Yuan B; Chen HD; Xu L; Tian YN; Zhang A; He JX; Miao ZH Cancer Sci; 2018 Mar; 109(3):821-831. PubMed ID: 29274141 [TBL] [Abstract][Full Text] [Related]
16. PARP-1 protein expression in glioblastoma multiforme. Galia A; Calogero AE; Condorelli R; Fraggetta F; La Corte A; Ridolfo F; Bosco P; Castiglione R; Salemi M Eur J Histochem; 2012 Feb; 56(1):e9. PubMed ID: 22472897 [TBL] [Abstract][Full Text] [Related]
17. PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity. Gupta SK; Smith EJ; Mladek AC; Tian S; Decker PA; Kizilbash SH; Kitange GJ; Sarkaria JN Front Oncol; 2018; 8():670. PubMed ID: 30723695 [TBL] [Abstract][Full Text] [Related]
18. Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90. Dungey FA; Caldecott KW; Chalmers AJ Mol Cancer Ther; 2009 Aug; 8(8):2243-54. PubMed ID: 19671736 [TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells. Tentori L; Portarena I; Torino F; Scerrati M; Navarra P; Graziani G Glia; 2002 Oct; 40(1):44-54. PubMed ID: 12237842 [TBL] [Abstract][Full Text] [Related]
20. Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent. Sizemore ST; Mohammad R; Sizemore GM; Nowsheen S; Yu H; Ostrowski MC; Chakravarti A; Xia F Mol Cancer Res; 2018 Jul; 16(7):1092-1102. PubMed ID: 29592899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]